| Literature DB >> 25362711 |
Maria Laura Acosta Felquer1, Laura C Coates1, Enrique R Soriano1, Roberto Ranza1, Luis R Espinoza1, Philip S Helliwell1, Oliver FitzGerald1, Neil McHugh1, Euthalia Roussou1, Philip J Mease1.
Abstract
In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.Entities:
Keywords: BIOLOGICS; DISEASE MODIFYING ANTIRHEUMATIC DRUGS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; THERAPEUTIC STRATEGIES; TUMOR NECROSIS FACTOR INHIBITORS
Mesh：
Substances：
Year: 2014 PMID： 25362711 DOI： 10.3899/jrheum.140876
Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666